Suppr超能文献

p53活性持续升高的小鼠中的肿瘤抑制与正常衰老

Tumor suppression and normal aging in mice with constitutively high p53 activity.

作者信息

Mendrysa Susan M, O'Leary Kathleen A, McElwee Matthew K, Michalowski Jennifer, Eisenman Robert N, Powell Douglas A, Perry Mary Ellen

机构信息

Department of Oncology, University of Wisconsin, Madison, 53706, USA.

出版信息

Genes Dev. 2006 Jan 1;20(1):16-21. doi: 10.1101/gad.1378506.

Abstract

The p53 inhibitor murine double-minute gene 2 (Mdm2) is a target for potential cancer therapies, however increased p53 function can be lethal. To directly address whether reduced Mdm2 function can inhibit tumorigenesis without causing detrimental side effects, we exploited a hypomorphic murine allele of mdm2 to compare the effects of decreased levels of Mdm2 and hence increased p53 activity on tumorigenesis and life span in mice. Here we report that mice with decreased levels of Mdm2 are resistant to tumor formation yet do not age prematurely, supporting the notion that Mdm2 is a promising target for cancer therapeutics.

摘要

p53抑制剂小鼠双微体基因2(Mdm2)是潜在癌症治疗的靶点,然而p53功能增强可能具有致死性。为了直接探究Mdm2功能降低是否能抑制肿瘤发生而不产生有害副作用,我们利用mdm2的一个低表达小鼠等位基因,比较Mdm2水平降低从而p53活性增加对小鼠肿瘤发生和寿命的影响。在此我们报告,Mdm2水平降低的小鼠对肿瘤形成具有抗性,但不会过早衰老,这支持了Mdm2是癌症治疗有前景靶点的观点。

相似文献

1
Tumor suppression and normal aging in mice with constitutively high p53 activity.
Genes Dev. 2006 Jan 1;20(1):16-21. doi: 10.1101/gad.1378506.
4
Distinct downstream targets manifest p53-dependent pathologies in mice.
Oncogene. 2016 Nov 3;35(44):5713-5721. doi: 10.1038/onc.2016.111. Epub 2016 Apr 11.
6
Tumor suppression by p53 without accelerated aging: just enough of a good thing?
Cell Cycle. 2006 Apr;5(7):714-7. doi: 10.4161/cc.5.7.2632. Epub 2006 Apr 1.
7
Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.
Mol Cell Biol. 2007 Aug;27(15):5479-85. doi: 10.1128/MCB.00555-06. Epub 2007 May 25.
8
Relevance of the p53-MDM2 axis to aging.
Cell Death Differ. 2018 Jan;25(1):169-179. doi: 10.1038/cdd.2017.187. Epub 2017 Dec 1.
10
RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
Cancer Res. 2016 Sep 1;76(17):5030-9. doi: 10.1158/0008-5472.CAN-15-3420. Epub 2016 Jul 11.

引用本文的文献

1
ZNF768 loss amplifies p53 action and reduces lung tumorigenesis in mice.
Oncogene. 2025 Mar 25. doi: 10.1038/s41388-025-03352-w.
2
3
Characterization of an Hypomorphic Allele in a Diethylnitrosamine-Induced Liver Carcinogenesis Model.
Cancers (Basel). 2023 Sep 16;15(18):4596. doi: 10.3390/cancers15184596.
5
Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program.
Cell Death Differ. 2023 Apr;30(4):897-905. doi: 10.1038/s41418-023-01123-2. Epub 2023 Feb 8.
6
How can aging be reversed? Exploring rejuvenation from a damage-based perspective.
Adv Genet (Hoboken). 2020 Aug 10;1(1):e10025. doi: 10.1002/ggn2.10025. eCollection 2020 Dec.
7
MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging.
Biology (Basel). 2022 Jun 8;11(6):881. doi: 10.3390/biology11060881.
8
Partial p53 reactivation is sufficient to induce cancer regression.
J Exp Clin Cancer Res. 2022 Mar 2;41(1):80. doi: 10.1186/s13046-022-02269-6.
9
Alterations of the Mdm2 C-Terminus Differentially Impact Its Function In Vivo.
Cancer Res. 2022 Apr 1;82(7):1313-1320. doi: 10.1158/0008-5472.CAN-21-2381.
10
p53 partial loss-of-function mutations sensitize to chemotherapy.
Oncogene. 2022 Feb;41(7):1011-1023. doi: 10.1038/s41388-021-02141-5. Epub 2021 Dec 14.

本文引用的文献

1
p53 isoforms can regulate p53 transcriptional activity.
Genes Dev. 2005 Sep 15;19(18):2122-37. doi: 10.1101/gad.1339905. Epub 2005 Aug 30.
2
Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells.
Cancer Cell. 2005 Jun;7(6):547-59. doi: 10.1016/j.ccr.2005.04.029.
3
Hereditary colorectal cancer syndromes.
Cancer Causes Control. 2005 Apr;16(3):201-13. doi: 10.1007/s10552-004-3488-4.
4
Complicating the role of p53 in aging.
Aging Cell. 2005 Jun;4(3):157-60. doi: 10.1111/j.1474-9726.2005.00154.x.
6
Turning the key on p53.
Nature. 2004 Feb 26;427(6977):789-90. doi: 10.1038/427789a.
7
Modulation of mammalian life span by the short isoform of p53.
Genes Dev. 2004 Feb 1;18(3):306-19. doi: 10.1101/gad.1162404.
8
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Science. 2004 Feb 6;303(5659):844-8. doi: 10.1126/science.1092472. Epub 2004 Jan 2.
9
Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses.
J Biol Chem. 2003 Oct 17;278(42):41028-33. doi: 10.1074/jbc.M306938200. Epub 2003 Aug 8.
10
mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation.
Mol Cell Biol. 2003 Jan;23(2):462-72. doi: 10.1128/MCB.23.2.462-473.2003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验